$89.2 Million is the total value of M28 Capital Management LP's 13 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WVE | Buy | WAVE LIFE SCIENCES LTD | $26,917,000 | +130.1% | 8,282,204 | +41.6% | 30.17% | +180.5% |
| ADAGIO THERAPEUTICS INC | $20,986,000 | -28.1% | 6,398,250 | 0.0% | 23.53% | -12.3% | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $9,851,000 | -13.2% | 715,880 | 0.0% | 11.04% | +5.8% | |
| STOK | STOKE THERAPEUTICS INC | $6,964,000 | -37.2% | 527,150 | 0.0% | 7.81% | -23.5% | |
| BBIO | BRIDGEBIO PHARMA INC | $4,233,000 | -10.5% | 466,200 | 0.0% | 4.74% | +9.1% | |
| CRIS | CURIS INC | $4,178,000 | -58.6% | 4,243,293 | 0.0% | 4.68% | -49.6% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $4,108,000 | -39.7% | 61,200 | -26.2% | 4.60% | -26.5% |
| TGTX | Sell | TG THERAPEUTICS INC | $3,086,000 | -69.0% | 726,200 | -30.7% | 3.46% | -62.3% |
| LPTX | LEAP THERAPEUTICS INC | $3,064,000 | -34.3% | 2,664,400 | 0.0% | 3.44% | -19.9% | |
| VERV | VERVE THERAPEUTICS INC | $2,727,000 | -33.0% | 178,500 | 0.0% | 3.06% | -18.4% | |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $2,097,000 | -42.0% | 269,253 | -30.8% | 2.35% | -29.3% |
| PRQR | PROQR THERAPEUTICS N V | $779,000 | -14.1% | 1,001,800 | 0.0% | 0.87% | +4.7% | |
| NEXI | NEXIMMUNE INC | $215,000 | -61.7% | 133,442 | 0.0% | 0.24% | -53.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD | 8 | Q3 2023 | 46.4% |
| INVIVYD INC | 8 | Q3 2023 | 32.1% |
| ROCKET PHARMACEUTICALS INC | 8 | Q3 2023 | 16.6% |
| BRIDGEBIO PHARMA INC | 8 | Q3 2023 | 6.1% |
| TG THERAPEUTICS INC | 8 | Q3 2023 | 9.2% |
| NEXIMMUNE INC | 8 | Q3 2023 | 0.5% |
| STOKE THERAPEUTICS INC | 7 | Q2 2023 | 10.2% |
| CURIS INC | 7 | Q2 2023 | 9.7% |
| PROQR THRAPEUTICS N V | 7 | Q3 2023 | 6.7% |
| ATARA BIOTHERAPEUTICS INC | 5 | Q1 2023 | 5.6% |
View M28 Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adagio Therapeutics, Inc. | August 19, 2022 | 9,248,250 | 8.5% |
View M28 Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-05-25 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-10 |
View M28 Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.